Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer

• Published in: Surgical endoscopy Vol. 28; no. 2; pp. 492 - 499
• Main Authors: Cash, J. Christian, Zehetner, Joerg, Hedayati, Bobak, Bildzukewicz, Nikolai A., Katkhouda, Namir, Mason, Rodney J., Lipham, John C.
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.02.2014; Springer Nature B.V
• Subjects: Abdominal Surgery; Aged; Aged, 80 and over; California - epidemiology; Cardiovascular disease; Esophageal cancer; Esophageal Neoplasms - mortality; Esophageal Neoplasms - surgery; Esophagectomy - methods; Female; Follow-Up Studies; Gastroenterology; Gynecology; Hepatology; Humans; Laparoscopy; Laparoscopy - methods; Length of Stay - trends; Lymphatic system; Male; Medicine; Medicine & Public Health; Middle Aged; Morbidity; Mortality; Ostomy; Proctology; Retrospective Studies; Surgery; Surgical anastomosis; Survival Rate - trends; Treatment Outcome; California; United States > US; Laparoscopic transhiatal esophagectomy; Esophageal cancer; Minimally invasive
• ISSN: 0930-2794; 1432-2218
• DOI: 10.1007/s00464-013-3230-y

Background Most published minimally invasive esophagectomy techniques involve a multiple field approach, including laparoscopic and thoracoscopic esophageal mobilization. Laparoscopic transhiatal esophagectomy (LTE) should potentially reduce the complications associated with thoracotomy. This study aims to compare outcomes of LTE with open transhiatal esophagectomy (OTE) and en-bloc esophagectomy (EBE). Methods Retrospective chart review was performed on all patients who had an LTE for cancer between July 2008 and July 2012 at our institution. Data was compared with an historic cohort of patients who underwent OTE and EBE at the same institution from July 2002 to July 2008. Results There were 33 patients with LTE, compared with 60 patients with OTE and 139 with EBE. The presence of minor operative complications was similar ( p  = 0.36), but major complications were significantly less common in the LTE group (12, 23 and 33 %, respectively; p  = 0.04). The median number of blood transfusions during hospitalization was significantly lower in the LTE group (0, 2.5 and 3, respectively; p  = 0.005). Median tumor size was significantly smaller (1.5, 2.2, and 3 cm, respectively; p  = 0.03), but the LTE group had a significantly higher percentage of patients with neoadjuvant treatment (39, 14 and 29 %, respectively; p  = 0.008). Median lymph node yield for LTE was lower (24, 36 and 48, respectively; p  < 0.0001), but the percentage of patients with positive nodes was similar (33, 33 and 39 %, respectively; p  = 0.69). Mortality was equivalent among the groups (0, 2 and 4 %, respectively; p  = 0.38). The median LOS for the LTE group was significantly lower (10, 13 and 15 days, respectively; p  < 0.0001). Overall survival was not different between the three groups ( p  = 0.65), with median survival at 24 months of 70, 65 and 65 %, respectively. Conclusion LTE can be performed safely with less major complications and shorter hospital stay than open esophagectomy. The reduced lymph-node harvest did not impact overall survival.